Month: May 2020

Las Vegas, NV, May 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — MJ Holdings, Inc. (OTCPK: MJNE) (the “Company”): While the Covid-19 pandemic has caused the Nevada cannabis industry to face many challenges over the past seven weeks, most Las Vegas dispensaries have reopened under new social distancing rules. We are starting to see increased demand for product at the retail level and hope that our dispensary customers will start placing orders from us in the next few weeks. The Company has received approximately $200,000 in short term financing from loans made by Pyyros One, LLC (“Pyyros”). The Company’s Chairman and CEO, Paris Balaouras, is the sole beneficiary of the trust that manages Pyyros. The principal, of the interest only loans, is due in February and March of 2021 and is being utilized to cover a portion of lost...

Please find attached the Q1 2020 presentation to be held at the digital meeting today at 11:00 UK time (12:00pm CET / 06:00 EST).To join the digital meeting, please click this link or copy and paste the following address into your browser: https://bit.ly/3fEyPXGAberdeen, 13 May 2020 For further information please contact:Jens Berge, CEOPhone: +44 1224 737900Cathrine Haavind, IR ManagerPhone: +47 93 42 84 64Email: ch@awilcodrilling.comThis information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. AttachmentAWDR Q1 2020 pres

SSH.COM Named an “Overall Leader” in 2020 KuppingerCole Leadership Compass for Privileged Access ManagementSSH.COM Rises from “Challenger” to “Leader” Across All Categories in 2020Helsinki, Finland – May 13, 2020 – SSH.COM today announced that it has been named an “Overall Leader” in the latest iteration of KuppingerCole’s Leadership Compass for Privileged Access Management (PAM).The Leadership Compass provides a detailed analysis of the PAM market and its key players to help information security leaders find the right vendors and products that best fit their cybersecurity needs. For its 2020 report, KuppingerCole evaluated 25 vendors across three Leadership categories: Product Leadership, Innovation Leadership, and Market Leadership.In addition to earning the prestigious position of “Overall Leader,” SSH.COM was also named a Leader in...

DECLARATIONDU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTEAU 30 AVRIL 2020Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMFCette déclaration est en ligne sur le site internet d’Elis www.corporate-elis.com(Rubrique Relations Investisseurs / Information Réglementée / Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital de la société)DISCLOSUREOF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTSAS OF 30 APRIL 2020This disclosure is on Elis web site www.corporate-elis.com(section Investor Relations / Regulatory Information / Monthly information concerning the total number of voting rights and shares that make up the company’s capital) AttachmentDisclosure of the number of shares forming the capital and...

DECLARATIONDU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTEAU 30 AVRIL 2020Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMFCette déclaration est en ligne sur le site internet d’Elis www.corporate-elis.com(Rubrique Relations Investisseurs / Information Réglementée / Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital de la société)DISCLOSUREOF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTSAS OF 30 APRIL 2020This disclosure is on Elis web site www.corporate-elis.comPièce jointeDéclaration du nombre d’actions composant le capital et du nombre total de droits de vote au 30 04 2020

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 13, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need in pain management, ophthalmology and oncology, today announced financial results for the first quarter ending March 31, 2020, and provided a business update.“The beginning of 2020 saw a pandemic that threatened public health globally and devastated the world economy. At our headquarters in Taiwan, we are lucky to still have the luxury of normal daily routines, like eating out and going to work, because of early actions that the government implemented to prevent the spread of COVID-19. Moreover, we are thankful to report that COVID-19 has only had minimal impact on the progress of our ongoing clinical trials,”...

Á aðalfundi félagsins sem haldinn var þann 19. mars s.l. var tekin ákvörðun um að fresta ákvörðun um greiðslu arðs vegna reikningsársins 2019 til framhaldsaðalfundar, sem haldinn yrði innan tveggja mánaða frá aðalfundardegi.Stjórn Vátryggingafélags Íslands hf. hefur boðað til framhaldsaðalfundar í félaginu sem haldinn verður í höfuðstöðvum félagsins að Ármúla 3, þriðjudaginn 19. maí 2020. Fundurinn hefst kl. 16:00.  Hluthafar eru beðnir um að kynna sér vandlega leiðbeiningar um atkvæðagreiðslu og rafræna þátttöku að neðan og í meðfylgjandi viðhengi.Á dagskrá fundarins eru eftirfarandi mál:Ákvörðun um tillögu stjórnar um hvernig fara skuli með hagnað félagsins og greiðslu arðsStjórn félagsins leggur til að enginn arður verði greiddur vegna ársins 2019 og að hagnaður ársins 2019 komi til hækkunar á eigin fé félagsins.Önnur mál löglega fram...

  Fondsbørsmeddelelse nr. 09/2020 Markant ordre styrker cBrain i TysklandKøbenhavn, 13. maj 2020cBrain har netop indgået den hidtil største enkeltstående aftale i selskabets historie.Aftalen, som er på et to-cifret millionbeløb, er indgået i Tyskland. Der er tale om yderligere salg til en eksisterende kunde, og det forventes, at aftalen vil medføre en videre udbygning af organisationen i cBrains tyske afdeling.I den seneste kvartalsmeddelelse omtalte cBrain, at det er lykkedes at komme ind hos en af de store myndigheder i den tyske centraladministration. cBrain leverer fagsystemer til kunden, som konfigureres og opsættes baseret på cBrains F2 standardsoftware. cBrain oplyste samtidig, at myndigheden, som har afdelinger i alle tyske delstater, repræsenterer et stort potentiale for yderligere salg og leverancer.Det er derfor særdeles glædeligt...

Leverkusen, Germany, May 13, 2020 (GLOBE NEWSWIRE) — Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or “Biofrontera”), an international biopharmaceutical company, today comments on certain litigation in California state court between the Company and DUSA Pharmaceuticals, Inc. (“DUSA”).In 2018, the Company sued DUSA Pharmaceuticals, Inc. in California state court alleging that DUSA engaged in unfair competition by providing excessive product samples to physicians and by using its distributor to inflate product prices. After filing suit, DUSA stopped using Foundation Care as its distributor to dispense its drug products, which was in substantial part the Company’s goal in filing this lawsuit. The court also ruled early in the case that Biofrontera adequately alleged claims against DUSA based on DUSA engaging...